Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 19/20 | 1.00 |
| ▸ | FKBP5 | Q13451 | 3/20 | 0.65 |
| ▸ | FKBP4 | Q02790 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14920841 | 1.00 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL14933815 | 0.93 | FKBP1A (0.87) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL5966173 | 0.85 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL15436070 | 0.84 | FKBP1A (0.73) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL19337370 | 0.82 | FKBP1A (0.70) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL6684784 | 0.82 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL14920732 | 0.82 | FKBP1A (0.72) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL7400429 | 0.81 | FKBP1A (1.00) | FKBP1A | |
| SCHEMBL5833651 | 0.80 | FKBP1A (1.00) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL19337325 | 0.80 | FKBP1A (0.66) | FKBP1AFKBP5FKBP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013064703-A9 | FKBP SUBTYPE-SPECIFIC RAPAMYCIN ANALOGUE FOR USE IN TREATMENT OF DISEASES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013064703-A2 | FKBP SUBTYPE-SPECIFIC RAPAMYCIN ANALOGUE FOR USE IN TREATMENT OF DISEASES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-05-10 | — | — | WO | disclosed |